CXCL12 and intrahepatic cholangiocarcinoma: Our results reveal β-catenin-induced inactivation of CXCL12 expression as a major mechanism underlying impaired DC infiltration into LNM-ICC and provide a rationale for therapeutic strategies aiming at restoring intra-tumoral cDC function to promote effective anti-cancer immunity and abatement of lymph node metastasis.